4th Quarter - Report
BAKER & HOSTETLER LLP for ADVAXIS, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 34, the 21st Century Cures Act Policy issues relation to Public Law No. 112-144, the Food and Drug Administration Safety and Innovation Act, specifically Section 902 relating to the Breakthrough Therapy Designation for pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM HIGGINS | — |
| CHRIS JONES | — |
| TYLER THOMPSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.